To elucidate which cells are synthesizing tenascin in usual interstitial pn
eumonia (UIP) we have analyzed thoracoscopic or open lung biopsies from 30
patients with UIP by mRNA in situ hybridization, using S-35-labeled tenasci
n RNA probes. The phenotype of the cells expressing tenascin mRNA was confi
rmed by immunohistochemical stainings of serial sections with antibodies ag
ainst alpha-smooth muscle actin and human cytokeratin. The results demonstr
ate that tenascin is expressed at the foci of recent lesions consisting of
intralumenal or incorporating loose fibrotic buds. The cells expressing ten
ascin mRNA were located in and underneath the newly formed epithelium. Immu
nohistochemical stainings showed that the cells in the newly formed epithel
ium were strongly cytokeratin positive, and thus evidently regenerating typ
e 2 pneumocytes, while the cells underneath the newly formed epithelium wer
e alpha-smooth muscle actin positive and apparently myofibroblasts. Tenasci
n mRNA expression was clearly stronger and more frequent in myofibroblasts
than in type 2 pneumocytes, however. Weak tenascin mRNA expression was also
found in metaplastic bronchiolar-type epithelium and alveolar macrophages.
Our results are thus in good agreement with the previous studies showing t
hat tenascin is actively synthesized at the early fibrotic lesions in UIP.
Furthermore, results demonstrate that the interaction between the epitheliu
m and the underlying connective tissue plays a significant role in tenascin
synthesis and that myofibroblasts are mainly responsible for its synthesis
in fibroblastic foci of UIP.